Cardiovascular disease (CVD) is associated with more deaths than all cancers—and more deaths in women than breast cancer. This Cardiovascular Profile evaluates a thourough battery of traditional and advanced biomarkers to aid in early detection and modification of heart disease risk. This profile indicates whether a person’s cholesterol-carrying lipoproteins are predominantly healthy or atherogenic (plaque-producing). Measuring cholesterol alone does not provide the complete picture and can be misleading. SpectraCell’s Lipoprotein Particle (LPPTM) is an advanced technology which accurately measures both the density and number of lipoprotein particles. This information reveals potential heart disease problems that are often missed when only using a standard lipid panel to assess risk. This Lipoprotein Particle Profile – accurately measures the number and size of all lipoprotein particles; helpful in determining the best treatment since the most effective treatment option varies depending on which lipoprotein is elevated.
VLDL, LDL and non-HDL Particles – accurate number of lipoprotein particles stratified by size and type
Small Dense LDL – highly atherogenic; these are more dangerous because their small size allows them to more easily penetrate and damage the endothelial wall of blood vessels, thus contributing to atherosclerosis
HDL2b – protective lipoproteins that indicate how well HDL is clearing excess cholesterol
C Reactive Protein-(hs)
A total of 17 primary and secondary risk factors are evaluated to provide actionable information at a tremendous value.
Pre-Diabetes Biomarkers may also be added to this test, if indicated.
The PULs Cardiac Test is a blood test designed to help identify people who appear healthy but may have active heart disease which could result in a heart attack in the next five years. This test detects the early stages of heart disease with 7 unique protein biomarkers in the blood that are linked to unstable plaque to see if a heart attack may be likely in the next five period.5
Where’s the Research?
PULs has demonstrated accuracy in predicting risk for cardiac events and was validated in the Multi-Ethnic Study of Atherosclerosis (MESA).5 The biomarkers for this test have evolved from 15 years of research across multiple University centers. A large clinical trial, in a Cleveland-based clinic of over 50,000 base population, the PULs Cardiac Test identified 61% of patients who went on to have a cardiac event, and who would have been missed by established risk factors.6
Who should get a PULS Test?
If you are over the age of 40 and have one or more risk factors for coronary heart disease, consider this test. Risk factors include, but are not limited to:
family history of early heart disease
elevated LDL cholesterol
high blood sugar or diabetes
high blood pressure
overweight or obese
What can I do to lower my PULs score?
Focus on reducing risk factors. It’s what we do best. Naturopathic Medicine will help guide you through a healthier diet, better lifestyle choices, stress reduction, IV Vitamin restoration, exercise and in some cases, medications are helpful. But we always like to start with the basics first: “Let food be thy medicine and medicine be thy food” – Hippocrates.
Find out what your risk is today, we welcome your call. 250-868-0221